NXTC

NextCure, Inc.

NXTC · CIK 1661059 · Annual (10-K) · Last 6 years

Financial Trends

Revenue
20192024
Net Income−$56M
20192024
Operating CF−$41M
20192024
Free Cash Flow−$41M
20192024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue———$0.0B$0.0B$0.0B
Cost of Revenue——————
Gross Profit——————
R&D Expense$0.0B$0.0B$0.1B$0.1B$0.0B$0.0B
SG&A Expense——————
Operating Income$-0.1B$-0.1B$-0.1B$-0.1B$-0.0B$-0.0B
Net Income$-0.1B$-0.1B$-0.1B$-0.1B$-0.0B$-0.0B
EPS (Basic)$-1.99$-2.25$-2.69$-2.51——
EPS (Diluted)$-1.99$-2.25$-2.69$-2.51——

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.1B$0.1B$0.2B$0.2B$0.3B$0.4B
Current Assets$0.1B$0.1B$0.2B$0.2B$0.3B$0.3B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.1B$0.1B$0.2B$0.2B$0.3B$0.3B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.0B$-0.1B$-0.1B$-0.1B$-0.0B$-0.0B
Investing Cash Flow$0.1B$0.0B$0.1B$0.0B$0.0B$-0.3B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$-0.0B$-0.0B$0.2B
← Companies